Latest News

  • Kalbe Distributed 1,000 Knockers for Breast Cancer Survivors

    Tuesday, September 8, 2020
    Kalbe Distributed 1,000 Knockers for Breast Cancer Survivors

    Jakarta, 8 September 2020, PT Kalbe Farma Tbk (Kalbe) in collaboration with Knitted Knockers Indonesia and Indonesia Cancer Care Community (ICCC) as well as kitabisa.com launched 1,000 Knockers Movement that will be given for free for ladies who are survivors of breast cancer in Indonesia who had undergone mastectomy (removal of breast tissues) surgeries. The movement that is a part of Kalbe's Oncology Total Solution service, or commonly referred to as ONE ONCO, is a form of care for Indonesian ladies that are survivors of cancer after mastectomy to get back on their feet, smile, regain confidence, and return to productivity. 

  • Kalbe Donated Personal Protection Equipment for Floating Hospital

    Monday, August 31, 2020
    Kalbe Donated Personal Protection Equipment for Floating Hospital

    Jakarta, 31 August 2020, PT Kalbe Farma Tbk (Kalbe) in collaboration with doctorSHARE presented the aid of Personal Protection Equipment (PPE) in the forms of 4,200 surgical masks, 520 medical-grade hazmat suits, and 150 non-medical grade hazmat suits; through the Indonesia Global Compact Network (IGCN) to be distributed to 55 hospitals throughout Indonesia, specifically to the Floating Hospital that is initiated by doctorShare. The aid is a part of Kalbe's contribution in COVID-19 management in Indonesia. 

  • Kalbe-Genexine Presents Anemia Medication Ephepoetin-Alfa to Third-Phase Clinical Trial Patients

    Monday, August 24, 2020
    Kalbe-Genexine Presents Anemia Medication Ephepoetin-Alfa to Third-Phase Clinical Trial Patients

    Jakarta, 24 August 2020, PT Kalbe Farma Tbk (Kalbe) through its subsidiary Kalbe-Genexine Biologics (KGBio) today has enrolled the first patients as well as supplied the first dosage of the Ephepoetin Alpha (EPO-HyFc) medication for the global phase-3 clinical trial. The medication is designed to be used for anemia therapy for kidney patients who are chronic - non-dialysis. The research project that is dubbed as Helios is conducting the non-inferiority trial in comparison with methoxy polyethylene glycol-Epoetin Beta (Mircera). 

  • Klikdokter Supports BKKBN in Launching the Klikkb Application

    Thursday, August 20, 2020
    Klikdokter Supports BKKBN in Launching the Klikkb Application

    Jakarta, 20 August 2020, PT Kalbe Farma Tbk (Kalbe) through its subsidiary, KlikDokter, is supporting the National Population and Family Planning Agency (BKKBN) in launching the 'klikkb' application that will directly connect the acceptors of KB with midwives and allowing acceptors to receive interactive information, or counseling. The launch of klikkb is presented by dr. Hasto Wardoyo, Sp.OG(K), Chief of the National Population and Family Planning Agency (BKKBN), Dr. Daeng M Faqih, SH., MH., Chairman of the Indonesian Doctors' Association (IDI); and Bonny Anom, Deputy CEO of KlikDokter, at the headquarters of BKKBN in Jakarta.  

  • Kalbe Educates on Autoimmune Disease Sjogren's Syndrome

    Thursday, August 6, 2020
    Kalbe Educates on Autoimmune Disease Sjogren's Syndrome

    Jakarta, 6 August 2020, PT Kalbe Farma Tbk (Kalbe) held a webinar health education for the media with the theme 'Recognizing Sjögren's Syndrome: Autoimmune Disease that is often Undiagnosed,’ with speakers: Dr. dr. Alvina Widhani SpPD, K-AI, Clinical Immunological Allergy Division of the Internal Medicine Department of FKUI/RSCM/RSUI and Board of Trustees of the Indonesian Sjögren's Syndrome Foundation; and Ir. Yennel S. Suzia, MSc., Sjögren's Syndrome Survivor. 

RSS
12345Last